On 23 April 2026, Livzon Pharmaceutical Group Inc. (LIVZON PHARMA) announced that the following corporate documents are now available on both the company website (www.livzon.com.cn) and the Hong Kong Stock Exchange’s website (www.hkexnews.hk):
• 2025 Annual Report • Circular dated 23 April 2026 • Notice and Proxy Form for the 2025 Annual General Meeting • Notice and Proxy Form for the 2026 First Class Meeting of H-Shareholders
The board recommends shareholders and investors review the digital versions to ensure timely access to information. Non-registered holders experiencing difficulty with electronic access may obtain printed copies free of charge by completing the enclosed request form and sending it to the Hong Kong branch share registrar, Tricor Investor Services Ltd., at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or by emailing 1513-ecom@vistra.com.
Stakeholders wishing to switch to electronic delivery must provide a functional email address through their respective banks, brokers, custodians, nominees, or HKSCC Nominees Ltd. Until a valid email address is registered, non-registered holders will continue to receive hard-copy notices of publication.
Enquiries can be directed to Tricor Investor Services’ hotline at (852) 2980 1333, Monday to Friday, 9:00 a.m. to 6:00 p.m. (excluding public holidays).
Comments